These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 10527563

  • 21. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL, Gillogly M, Kawano K, Efferson CL, Lee JE, Ross M, Wang X, Ferrone S, Ioannides CG.
    Cancer Res; 2004 Aug 01; 64(15):5481-8. PubMed ID: 15289358
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T, Uehara S, Ariga H, Tokunaga T, Kariyone A, Tamura T, Takatsu K.
    Immunology; 2006 Jan 01; 117(1):47-58. PubMed ID: 16423040
    [Abstract] [Full Text] [Related]

  • 24. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F.
    Clin Cancer Res; 2008 Nov 15; 14(22):7292-303. PubMed ID: 18974390
    [Abstract] [Full Text] [Related]

  • 25. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 15; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

  • 26. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
    Wong R, Lau R, Chang J, Kuus-Reichel T, Brichard V, Bruck C, Weber J.
    Clin Cancer Res; 2004 Aug 01; 10(15):5004-13. PubMed ID: 15297401
    [Abstract] [Full Text] [Related]

  • 27. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 28. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P.
    Antiviral Res; 2007 Apr 04; 74(1):25-35. PubMed ID: 17275104
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.
    Grohmann U, Bianchi R, Fioretti MC, Fallarino F, Binaglia L, Uyttenhove C, Van Pel A, Boon T, Puccetti P.
    Eur J Immunol; 1995 Oct 04; 25(10):2797-802. PubMed ID: 7589074
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.
    Ben-Nun A, Yossefi S, Lehmann D.
    Eur J Immunol; 1993 Mar 04; 23(3):689-96. PubMed ID: 8095458
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 36. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A, De Magistris MT, Rappuoli R.
    Tokai J Exp Clin Med; 1988 Nov 15; 13 Suppl():253-7. PubMed ID: 2908527
    [Abstract] [Full Text] [Related]

  • 37. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C, Bauche C, Ladant D, Leclerc C.
    Vaccine; 2004 Dec 16; 23(5):604-14. PubMed ID: 15542180
    [Abstract] [Full Text] [Related]

  • 38. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH, Cui H, Feng J, Yang WL, Li Y, Fu TY.
    Ai Zheng; 2004 Jul 16; 23(7):777-81. PubMed ID: 15248911
    [Abstract] [Full Text] [Related]

  • 39. CD4+ T cell response to the human acetylcholine receptor alpha subunit in myasthenia gravis. A study with synthetic peptides.
    Protti MP, Manfredi AA, Straub C, Howard JF, Conti-Tronconi BM.
    J Immunol; 1990 Feb 15; 144(4):1276-81. PubMed ID: 1968078
    [Abstract] [Full Text] [Related]

  • 40. [MHC tetramers: tracking specific immunity].
    Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.
    Acta Med Croatica; 2003 Feb 15; 57(4):255-9. PubMed ID: 14639858
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.